Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
| Report ID | 119316 |
| Drug Identification Number | 02458608 |
| Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
| Common or Proper name | NAPROXEN/ESOMEPRAZOLE MR |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | NAPROXEN ESOMEPRAZOLE |
| Strength(s) | 375MG 20MG |
| Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60BT |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-07-15 |
| Actual start date | 2020-07-11 |
| Estimated end date | 2020-09-29 |
| Actual end date | 2020-09-30 |
| Shortage status | Resolved |
| Updated date | 2020-10-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2020-10-01 | English | Compare |
| v20 | 2020-09-30 | French | Compare |
| v19 | 2020-09-30 | English | Compare |
| v18 | 2020-09-22 | French | Compare |
| v17 | 2020-09-22 | English | Compare |
| v16 | 2020-09-14 | French | Compare |
| v15 | 2020-09-14 | English | Compare |
| v14 | 2020-09-09 | French | Compare |
| v13 | 2020-09-09 | English | Compare |
| v12 | 2020-09-01 | French | Compare |
| v11 | 2020-09-01 | English | Compare |
| v10 | 2020-08-12 | French | Compare |
| v9 | 2020-08-12 | English | Compare |
| v8 | 2020-07-28 | French | Compare |
| v7 | 2020-07-28 | English | Compare |
| v6 | 2020-07-21 | French | Compare |
| v5 | 2020-07-21 | English | Compare |
| v4 | 2020-07-14 | French | Compare |
| v3 | 2020-07-14 | English | Compare |
| v2 | 2020-07-02 | French | Compare |